Specific niche view of the structured sector hierarchy. Useful for precedent work where broader sector slices include too much noise.
| Target | Buyer / Investor | Sector | Geo | Transaction size | EV / EBITDA |
|---|---|---|---|---|---|
| OPHAM | CFAO Healthcare | Pharmaceuticals Wholesale | $10.2M – $13.8M | 5× – 7× | |
| P.R. Chemicals | DKSH | Pharmaceuticals Wholesale | $4.8M – $6.4M | 5× – 7× | |
| Pharmacy distribution network | Cosmos Health | Pharmaceuticals Wholesale | $11.5M | 5× – 7× | |
| Orba DVX Healthcare Co., Ltd. | Orba Healthcare Holdings, DVX | Pharmaceuticals Wholesale | $57.0M – $77.0M | 5× – 7× | |
| Apex Healthcare Berhad | Quadria Capital | Pharmaceuticals Wholesale | $470M | 10× – 12× | |
| 日新薬品 | メディカル一光グループ | Pharmaceuticals Wholesale | $2.8M – $3.4M | 5× – 6× | |
| Remedia | Alfresa Holdings | Pharmaceuticals Wholesale | $55.0M – $65.0M | 9× – 10× | |
| Farmadent, Gopharm | Salus Group | Pharmaceuticals Wholesale | $23.3M | 0.6× | |
| Adalvo Limited | EQT | Pharmaceuticals Wholesale | $450M – $540M | 12× – 14× | |
| PT Hale International | PT Forsta Kalmedic Global | Pharmaceuticals Wholesale | $30.0M – $38.0M | 7× – 8× |
Bins are observed deal frequencies across disclosed transactions. Use as a directional reference, not a target valuation.
Use the directory on the recent deals hub to switch between countries, sectors and sub-sectors. A free account unlocks the structured filters that go beyond the public view.